Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases

Ralph Hoessel(University of Kaiserslautern), Sophie Leclerc(Centre National de la Recherche Scientifique), Jane Endicott(University of Oxford), Martin E. M. Nobel(MRC Laboratory of Molecular Biology), Alison M. Lawrie(MRC Laboratory of Molecular Biology), Paul Tunnah(MRC Laboratory of Molecular Biology), Maryse Leost(Station Biologique de Roscoff), Eve Damiens(Centre National de la Recherche Scientifique), Dominique Marie(Centre National de la Recherche Scientifique), Doris Marko(University of Kaiserslautern), Ellen Niederberger(University of Kaiserslautern), Weici Tang(University of Kaiserslautern), Gerhard Eisenbrand(University of Kaiserslautern), Laurent Meijer(Centre National de la Recherche Scientifique)
Nature Cell Biology
May 1, 1999
Cited by 814

Abstract


Related Papers

No related papers found

Powered by citation graph analysis